Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India · Delayed Price · Currency is INR | Market Cap | 4.00T -5.1% |
| Revenue (ttm) | 568.09B +10.1% |
| Net Income | 109.15B -4.5% |
| EPS | 45.45 -4.7% |
| Shares Out | 2.40B |
| PE Ratio | 36.71 |
| Forward PE | 32.48 |
| Dividend | 16.00 (0.95%) |
| Ex-Dividend Date | Feb 5, 2026 |
| Volume | 3,630,775 |
| Average Volume | 3,400,410 |
| Open | 1,667.20 |
| Previous Close | 1,668.60 |
| Day's Range | 1,659.90 - 1,682.90 |
| 52-Week Range | 1,548.00 - 1,851.20 |
| Beta | 0.11 |
| RSI | 40.90 |
| Earnings Date | May 22, 2026 |
About NSE:SUNPHARMA
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, urology, dermatology, respira... [Read more]
Financial Performance
In fiscal year 2025, NSE:SUNPHARMA's revenue was 525.78 billion, an increase of 8.42% compared to the previous year's 484.97 billion. Earnings were 109.29 billion, an increase of 14.12%.
Financial StatementsNews
Nifty 50 top losers today, April 17: Wipro, HDFC Life, Sun Pharma, Bajaj Auto, Mahindra & Mahindra and more
Indian benchmark indices ended in the red on April 17, with the Nifty 50 closing at 24,353.55, down 156.80 points or 0.65%. The BSE Sensex declined 504.86 points or 0.65%…
Organon (OGN) Shares Rise as Sun Pharma and Grünenthal Eye Acquisition
Organon (OGN) Shares Rise as Sun Pharma and Grünenthal Eye Acquisition
Organon & Co. (OGN) Stock Rises 4% to $9.6
Organon & Co. shares rocketed 24.7% higher on Friday, April 10, 2026, closing at $8.62 after reports emerged that Sun Pharmaceutical submitted a binding offe... The post Organon & Co. (OGN) Stock Rise...
Top losers among Nifty 50 stocks in midday trades today, April 16: Titan Company falls 1.7%, ONGC down 1.6%, Sun Pharma drops 1.5%
Indian benchmark indices traded lower in midday deals on Thursday, April 16, with the NIFTY 50 down 70.60 points or 0.29% at 24,160.70 as of 12:30 PM IST. The SENSEX…
Sun Pharma places aggressive bid for Organon— contradicting company's own earlier clarification of speculative reports
Sun Pharmaceutical Industries has placed an aggressive bid for Organon, Bloomberg reported on Wednesday — a development that directly contradicts Sun Pharma's own regulatory clarification filed with B...
Buy or Sell Organon Stock in 2026? Takeover Buzz Lifts Shares 28% as Analysts Stay Cautious
JERSEY CITY, N.J. — Shares of Organon & Co. surged more than 27% on April 10, 2026, closing at $8.83 after reports emerged that India's Sun Pharmaceutical Industries is nearing a potential $12 billion...
Organon (OGN) Surges 23% on $12B Acquisition Offer from Sun Pharmaceutical
Organon (OGN) Surges 23% on $12B Acquisition Offer from Sun Pharmaceutical
Organon Jumps 25% As Report Cites $12 Billion Sun Pharma Offer
Organon Jumps 25% As Report Cites $12 Billion Sun Pharma Offer
Organon (OGN) Gains Traction on Sun Pharma Acquisition Speculation
Organon (OGN) Gains Traction on Sun Pharma Acquisition Speculation
Sun Pharma Nears Final Offer For Organon In Largest Overseas Bet
Sun Pharma prepares $12 billion Organon bid after due diligence, advancing financing for its biggest global acquisition push. ... Full story available on Benzinga.com
Organon (OGN) Draws Interest from Sun Pharmaceutical in Potential $12B Offer
Organon (OGN) Draws Interest from Sun Pharmaceutical in Potential $12B Offer
Organon (OGN) Shares Surge as Sun Pharma Submits $12B Bid
Organon (OGN) Shares Surge as Sun Pharma Submits $12B Bid
Sun Pharma Moves Forward with $12 Billion Offer for Organon (OGN)
Sun Pharma Moves Forward with $12 Billion Offer for Organon (OGN)
Nifty 50 top losers today, April 10: Coal India, Sun Pharma, Infosys, TCS, Tech Mahindra and more
Indian equity benchmarks ended on a strong note on April 10, with the Nifty 50 closing above the 24,000 mark. The BSE Sensex gained 918.60 points or 1.20% to settle…
Pharma sector stocks today, April 10: Sun Pharma falls 4%, Cohance Lifesciences surge 15%, Suven Life up 5%
The Indian pharma and healthcare sector is trading broadly positive on April 10, 2026, with a clear majority of stocks in the green. Out of approximately 85 pharma and healthcare…
Sun Pharma Wins Legal Battle Over Pantocid's Name; Uses And Side Effects Of Proton Pump Inhibitors Explained
Pantocid Tablet belongs to a class of medicines known as proton pump inhibitors (PPIs). It is primarily used to reduce the amount of acid produced in your stomach.
Pharma sector stocks today, April 6: Shilpa Medicare down 3.07%, Ipca Labs decline 2.42%, Sun Pharma falls 1.42%
Indian pharma sector stocks traded mostly lower in early deals on April 6, 2026, with the majority of listed names showing declines of 0.2% to over 3% around 9:30-9:40 AM…
Why Sun Pharma shares are falling nearly 3% today? Epxlained
Shares of Sun Pharma Advanced Research Company declined over 2 percent in Monday’s session, trading near Rs 121, after fresh concerns emerged following a major policy move by Donald Trump…
Nifty 50 top losers today, April 2: Asian Paints, Eicher Motors, Sun Pharma lead declines as market ends marginally higher
Indian equity indices ended a volatile session on April 2 with marginal gains, even as several heavyweight stocks dragged. The Nifty 50 closed above the 22,700 mark, while the BSE…
Pharma sector stocks fall sharply today: Sun Pharma down 4.89%, Aurobindo Pharma falls 4.48%, Biocon drops 4.67%
Indian pharmaceutical stocks declined in early trade on April 2, 2026, with most listed companies showing losses on both BSE and NSE. As of approximately 9:23-9:25 AM IST, the majority…
Why are Sun Pharma shares down over 6% today? Explained
Shares of Sun Pharmaceutical Industries Ltd declined sharply by 6% in early trade on Thursday, reacting to reports that the United States may impose tariffs on imported medicines. According to…
Fortress Biotech's Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million
MIAMI, March 30, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) ("Fortress") and its majority-owned subsidiary, Cyprium Therapeutics, Inc. ("Cyprium"), today announced the closing of ...
Sun Pharmaceutical reports clinical updates on Fibromun and Nidlegy trials
Sun Pharmaceutical Industries has announced significant updates regarding its partner Philogen's clinical trials for Fibromun and Nidlegy. The updates were disclosed as part of Philogen's financial re...
Sun Pharma to present 14 abstracts at 2026 AAD Annual Meeting
Sun Pharmaceutical Industries Limited is set to present 14 abstracts at the 2026 American Academy of Dermatology (AAD) Annual Meeting, scheduled from March 27-31 in Denver, Colorado. This presentation...
Nifty 50 top losers today, March 24: Coal India, Power Grid, Adani Enterprises, Sun Pharma and Cipla
Indian equity benchmarks ended on a strong note on March 24, with the Nifty closing above the 22,900 mark. The Sensex gained 1,372.06 points (1.89%) to settle at 74,068.45, while…